Atossa Therapeutics Inc (ATOS)
NASDAQ · Healthcare
Atossa Therapeutics Inc EBITDA 2011–2015
Atossa Therapeutics Inc annual/quarterly ebitda history and growth rate from 2011 to 2016. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Atossa Therapeutics Inc ebitda for the quarter ending March 31, 2016 was -2.3 M, a 29.82% decrease year-over-year.
- Atossa Therapeutics Inc ebitda for the twelve months ending March 31, 2016 was -9.6 M.
- Atossa Therapeutics Inc annual ebitda for 2015 was -12.5 M, a 6.80% increase from 2014.
- Atossa Therapeutics Inc annual ebitda for 2014 was -11.7 M, a 13.37% increase from 2013.
- Atossa Therapeutics Inc annual ebitda for 2013 was -10.3 M, a 108.80% increase from 2012.
- Atossa Therapeutics Inc annual ebitda for 2012 was -4.9 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Atossa Therapeutics Inc EBITDA — FAQ
Atossa Therapeutics Inc (ATOS) ebitda over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ATOS's ebitda history?
The chart and table above show Atossa Therapeutics Inc's ebitda by year and by quarter, including the growth rate.